WHO ICTRP trial
The impact of prebiotics and probiotics in Sjögrens syndrome-related dry eye
ACTRN12624000440527 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12624000440527 |
|---|---|
| Public title | The impact of prebiotics and probiotics in Sjögrens syndrome-related dry eye |
| Scientific title | The efficacy of prebiotics and probiotics in reducing ocular signs and symptoms of Sjögrens syndrome-related dry eye |
| Primary sponsor | The University of New South Wales |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Sjögrens syndrome-related dry eye; Sjögrens syndrome-related dry eye;Eye - Diseases / disorders of the eye;Inflammatory and Immune System - Autoimmune diseases |
| Interventions | The treatment group will receive probiotic and prebiotic supplements. Probiotic: - the dose administered: Two capsules daily; - the duration of administration: four months - the mode: oral Probiotic ingredient: Lactobacillus rhamnosus CUL… |
| Registration date | Oct 4, 2024 |
| Target size | 46 |
| Secondary IDs | iRECS5145 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: